Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers
Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed
| Condition(s) | Nicotine Use, Tobacco Use |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as we |
| Who can participate | Inclusion Criteria: Cancer Survivors including Current Cancer Patients * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment. * Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology). * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Informal Caregivers/Family Members of Cancer Survivors * Current self-reported user of any tobacco/nicotine product at time of baseli |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | University of Florida |
| Locations | Gainesville, Florida, United States |
| Start date | 2025-07-11 |
| NCT ID | NCT06851936 |
| Official listing | https://clinicaltrials.gov/study/NCT06851936 |